Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

21 trials with published results (12%)

Research Maturity

74 completed trials (42% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.3%

11 terminated out of 175 trials

Success Rate

87.1%

+0.5% vs benchmark

Late-Stage Pipeline

6%

11 trials in Phase 3/4

Results Transparency

28%

21 of 74 completed with results

Key Signals

21 with results87% success11 terminated

Data Visualizations

Phase Distribution

128Total
Not Applicable (90)
Early P 1 (1)
P 1 (11)
P 2 (15)
P 3 (7)
P 4 (4)

Trial Status

Completed74
Recruiting40
Unknown26
Not Yet Recruiting13
Terminated11
Active Not Recruiting6

Trial Success Rate

87.1%

Benchmark: 86.6%

Based on 74 completed trials

Clinical Trials (175)

Showing 20 of 20 trials
NCT06570681Not ApplicableRecruiting

Video Call Assisted Assessment of Acute Stroke

NCT04512690Not ApplicableCompleted

Spinal Cord Stimulation for Restoration of Arm and Hand Function in People With Subcortical Stroke

NCT07830927Not Yet Recruiting

Early Neurological Outcome in Pediatric Encephalitis

NCT05508789Phase 3Active Not Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT07056361Not ApplicableRecruiting

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control

NCT06344871Not ApplicableTerminatedPrimary

Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF

NCT07825675Not Yet Recruiting

EEG Abnormalities as Predictor of Outcome in Pediatric Encephalopathy

NCT06728592Not ApplicableRecruiting

Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group

NCT05386108Phase 1Recruiting

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

NCT03911388Phase 1Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT07802366Not ApplicableNot Yet Recruiting

Acceptability and Tolerance Market Research of a Slow Release, Phenylalanine-free Protein Substitute for the Dietary Management of Phenylketonuria

NCT07451769Not ApplicableRecruiting

Selective Activation of the Adrenomedullin Receptors in Migraine

NCT06993142Not ApplicableRecruiting

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

NCT06193252Not ApplicableRecruiting

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

NCT06121336Recruiting

PRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke

NCT04406818Not ApplicableActive Not Recruiting

Metabolic and Hemodynamic Reserve in Pediatric SCA

NCT07305948CompletedPrimary

Evaluation of a New MRI Technique to Reduce Breathing-Related Artifacts in Brain Imaging

NCT07063810Not ApplicableCompleted

NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.

NCT05007353Not ApplicableCompleted

The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study

NCT05378035Recruiting

DOAC in Chinese Patients With Atrial Fibrillation

Scroll to load more

Research Network

Activity Timeline